Description

BRENDAN VERMEIRE – MASTERING THE MENTAL MAP SEMINAR

– Identify the root causes of neuroinflammation and neurochemical imbalances causing Mental Health Dysfunction in your client and patient populations

– Learn how to regenerate and rewire the brain through Neuroplasticity by slowing down the pathophysiological mechanistic cascade specific to each neuroinflammatory condition

– Implement the latest research-supported strategies in creating new neural networks through dampening the fire of Microglial Activation

– Access the most effective lab test new to the market to objectively assess, navigate, heal and monitor microglial dysfunction and neuroinflammatory disorders

Microglial Activation Syndrome

Research has clearly demonstrated that Inflammation and Excitotoxicity are the driving forces behind Mental Illness and Neurodegeneration. Microglia, the residential immune cells of the CNS, have become the focal point of Mental Health Research due to their crucial role in regulating the neuroinflammatory and excitotoxic cascade, while profoundly impacting Neuroplasticity.

‘Microglial Activation Syndrome’ is the common underlying ‘root cause’ in Mental Illness and Neurodegeneration.


The Mental M.A.P™

Designed to be the most effective way to objectively assess, navigate, heal and monitor microglial dysfunction and neuroinflammatory disorders.

Includes the most reliable objective indices that accurately reflect oxidative and neuroinflammatory dysregulation that contribute to microglial activation, neurotransmitter imbalances and concomitant mental health dysfunction.

Specific for the following:

Anxiety & Depression

Bipolar Disorder

Major Depressive Disorder

Autism Spectrum Disorder (ASD)

PTSD & Schizophrenia

Neurodegenerative diseases

 


The constituent biomarkers of The Mental M.A.P.™ are the most reliable objective indices that accurately reflect oxidative and neuroinflammatory dysregulation that contribute to microglial activation, neurotransmitter imbalance and concomitant mental health dysfunction.

Core Markers Assessed: 

  • Homocysteine > assess methylation imbalances.
  • KPU > assess oxidative stress and pyrrole disorder.
  • MMP-9 > assess blood brain barrier disruption.
  • Myeloperoxidase > marker of microglial activation, neuroinflammation and oxidative stress.
  • Neopterin > indicates microglial, macrophage and immune activation.

Day 1:

Hour 1-2: The Mental Health Pandemic & an introduction to Microglial Activation Syndrome

Hour 3-4: The Molecular Mechanisms of ‘Microglial Activation Syndrome’ and Neuroplasticity

Hour 5-6: Introduction to The Mental M.A.P.™, biomarker selection and analysis

Day 2:

Hour 1-2​Functional Pattern Analysis specific to lab data

Hour 3-4: Designing bioindividualized protocols specific to each molecular target

Hour 5: Integrative intervention strategies for microglial inhibition and neuroplastic promotion

Hour 6: Client case study + Live Q&A